BioSpace News Archive

Titan Medical to Report First Quarter 2021 Financial Results May 17, 2021

EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, today announced that it will release its financial results for the first quarter ended March 31, 2021 after the markets close on Tuesday, May 11, 2021.

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has enrolled the first subject in a Phase 1b boosting regimen trial of its norovirus vaccine candidate.

5 mg/kg SC dose provides full receptor occupancy through Day 43 and complete suppression of TDAR after KLH challenge through at least Day 29

Abpro Corporation, a clinical stage biotechnology company developing next-generation antibody therapies, announced results from its study of ABP201, a novel bispecific antibody co-targeting VEGF and ANG2, for treatment of wet age-related macular degeneration and diabetic macular edema.

In recognition of World Sickle Cell Day, which falls on June 19, 2021, Global Blood Therapeutics, Inc. and the Sickle Cell Disease Association of America, Inc. launched “Lift Every Voice to Shine the Light on Sickle Cell” – a contest that will feature original spoken word pieces to raise awareness of sickle cell disease.

Ann Cunningham has a proven pharmaceutical commercial track record of more than 25 years delivering sales, marketing, and global life cycle product management expertise for many successful branded product campaigns for large pharmaceutical companies

Amgen Canada announced that AMGEVITA®, is now available in Canada for the treatment of 11 chronic inflammatory conditions.

Konica Minolta Precision Medicine, Inc. announced changes to its executive leadership team effective immediately.

IceCure Medical Ltd., developer of the minimally invasive cryoablation ProSense® System that destroys tumors by freezing, announced interim results from the Company’s ICE3 clinical trial for cryoablation of small low-risk breast cancer tumors.